This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
KLF4 / Krueppel-like factor 4 · IHC design guide
Design Immunohistochemistry for KLF4
Plan KLF4 chromogenic IHC around nuclear staining, especially in squamous epithelium (HPA tissue IHC). This guide covers fixation consistency, cell-specific controls, and interpretation of five annotated isoforms (UniProt).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
KLF4 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Nuclear staining in several tissues (HPA tissue IHC) | |
| Staining pattern | Nuclear staining, abundant in squamous epithelium (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6 HIER, heat-mediated (datasheet A00120) | |
| Positive control | Appendix+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A00120) | |
| Caveat | Staining varies by cell type across tissues (HPA tissue IHC) | |
| Regulation | BTRC promotes KLF4 degradation (UniProt) | |
| Isoform / epitope | Five isoforms; verify antibody epitope coverage (UniProt) |
Section 1
Recommended KLF4 IHC & IF Protocols
Compare the catalog antibody’s IHC-P protocol (datasheet: A00120) with three published KLF4 IHC protocols (PMC4100128; PMC12173638; PMC3198687).
| Sample | Paraffin-embedded rat small intestine tissue; fixative not specified (datasheet A00120) |
| Fixation | Image fixative and duration unreported (datasheet A00120); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: Citrate pH 6, 20 min (datasheet A00120) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A00120) |
| Primary antibody | Rabbit anti-KLF4, 2μg/ml (datasheet A00120) |
| Primary incubation | Overnight at 4 °C (datasheet A00120) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet A00120) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | KLF4-positive staining in endocrine cells of appendix (HPA tissue IHC: High). HPA tissue profile: Nuclear expression in several different tissues, highly abundant in squamous epithelium. No signal in the no-primary control. |
💡Decision noteStart with heat-mediated citrate retrieval at pH 6 (datasheet: A00120); the published microwave protocol also uses citrate at pH 6 (PMC12173638).
Section 2
What Is the Expected KLF4 Staining Pattern?
KLF4 should stain predominantly in nuclei, especially in squamous epithelial cells of esophagus and oral mucosa and respiratory epithelial cells of bronchus (HPA tissue IHC). UniProt also lists cytoplasmic localization and no transmembrane segment (UniProt O43474). HPA rates the tissue staining profile Enhanced, with medium consistency between antibody staining and RNA expression; assess the named cell populations rather than treating every cell in a tissue as positive (HPA tissue IHC).
| Distinct nuclear chromogen in esophageal or oral squamous epithelium, with little surrounding background (HPA tissue IHC). | This matches HPA's high staining in those cells and its predominantly nuclear tissue profile (HPA tissue IHC). Record the fraction and intensity of stained nuclei within the epithelial population (standard IHC practice). |
| Predominantly membranous staining, or chromogen outside recognizable cells, in a presumed positive section. | A membrane dominant pattern conflicts with KLF4's listed nuclear and cytoplasmic locations and lack of a transmembrane segment (UniProt O43474). Review morphology and the no primary control before assigning the signal to KLF4 (standard IHC practice). |
| Strong staining in adipocytes where HPA reports KLF4 as not detected (HPA tissue IHC). | Treat this as discordant, not proof that the tissue is wholly negative: HPA's call applies to adipocytes (HPA tissue IHC). Cross reactivity or endogenous detection activity is possible; compare a no primary control and a separate positive section (standard IHC practice). |
| Diffuse brown haze across epithelium, stroma and empty spaces, without crisp nuclear boundaries. | The distribution cannot be scored as HPA's cell localized nuclear pattern (HPA tissue IHC). Nonspecific antibody binding or detection background is possible; inspect a no primary control and reassess blocking, washes and chromogen development (standard IHC practice). |
| No nuclear signal in squamous epithelial cells of an esophageal positive control (HPA tissue IHC). | The assay has not demonstrated its expected positive pattern (HPA tissue IHC). Check section integrity, antibody and detection steps, and the antibody's documented IHC conditions before interpreting a study sample as negative (standard IHC practice). |
💡Expected KLF4 appearanceCall a section positive when recognizable squamous epithelial cells show clear, predominantly nuclear staining of appreciable intensity (HPA tissue IHC); diffuse haze or membrane dominant signal is discordant with the expected localization (HPA tissue IHC; UniProt O43474).
| Which cells anchor the positive control? | HPA reports high KLF4 in esophageal and oral squamous epithelium, bronchial respiratory epithelium, and endocrine cells of appendix, colon, duodenum and rectum (HPA tissue IHC). |
| Which cells are useful low or negative comparators? | HPA lists adipocytes as not detected in adipose tissue and breast, while kidney tubular cells and lung macrophages are low (HPA tissue IHC). Compare the specified cells, not entire organs. |
| How strong is the tissue evidence? | HPA calls the tissue profile Enhanced but reports medium consistency with RNA expression (HPA tissue IHC). Its listed antibody HPA002926 has Enhanced IHC validation (HPA antibodies). |
| Does isoform information change scoring? | UniProt lists five KLF4 isoforms (UniProt O43474). Their relative staining and recognition by a particular IHC antibody are not supplied; do not assign a staining difference to an isoform. |
| Is a surface or secreted pattern expected? | UniProt lists no transmembrane segment, signal peptide or propeptide, and places KLF4 in nucleus and cytoplasm (UniProt O43474). Surface staining needs independent verification. |
| What should IF/ICC show? | HPA reports nucleoplasm as the main location, with additional cytosol and microtubules in ICC-IF (HPA subcellular). Use that as a localization cross-check; it does not define an IHC chromogen pattern. |
| Situation | Likely cause | Next action |
|---|---|---|
| The positive control stains weakly despite recognizable squamous epithelium. | The observed result falls below HPA's high call for those cells (HPA tissue IHC); the failed step cannot be identified from that comparison alone. | Check the antibody's documented IHC dilution and retrieval conditions, reagent performance and detection controls (standard IHC practice). No KLF4-specific retrieval condition is supplied. |
| Only cytoplasmic staining appears in a high expressing epithelial population. | Cytoplasm is a listed KLF4 location, but HPA describes tissue expression as nuclear (UniProt O43474; HPA tissue IHC). | Score nuclear and cytoplasmic signals separately; compare a positive section and no primary control before accepting a cytoplasm only result (standard IHC practice). |
| A nominally negative tissue shows scattered positive cells. | HPA's not detected entries identify particular cell types; they do not certify every cell in the tissue as KLF4 negative (HPA tissue IHC). | Identify the stained cells morphologically and compare them with HPA's cell specific entry before calling the section a false positive (standard IHC practice; HPA tissue IHC). |
| Background appears in the no primary control. | Signal without primary antibody indicates a detection or tissue background contribution (standard IHC practice). | Review the detection system's recommended endogenous activity block and chromogen development, then repeat the no primary control (standard IHC practice). |
| Background appears only when primary antibody is included. | Nonspecific primary binding is possible when the no primary control is clean (standard IHC practice). | Recheck the antibody's IHC validation and documented dilution; optimize blocking and washes while retaining a known positive section (standard IHC practice). |
| A study sample is negative while its positive control stains as expected. | The assay has demonstrated detectable KLF4 in the HPA positive cell population, but that does not establish expression in every study sample (HPA tissue IHC; standard IHC practice). | Report the negative result for the evaluated cell population and preserve the control result; do not infer a fixation-specific KLF4 effect from these data (standard IHC practice). |
Experiment evidence
IHC & IF images showing KLF4 staining
A00120 · IHCIHC analysis of KLF4 using anti-KLF4 antibody (A00120). KLF4 was detected in paraffin-embedded section of rat small intestine tissue. Heat m
A00120 · IHCIHC analysis of KLF4 using anti-KLF4 antibody (A00120). KLF4 was detected in paraffin-embedded section of rat small intestine tissue. Heat m
A00120-3 · IHCIHC analysis of KLF4 using anti-KLF4 antibody (A00120-3). KLF4 was detected in a paraffin-embedded section of mouse stomach tissue. Heat med
A00120-3 · IHCIHC analysis of KLF4 using anti-KLF4 antibody (A00120-3). KLF4 was detected in a paraffin-embedded section of rat stomach tissue. Heat media
M00120-3 · IHCMouse colon was stained with Anti-KLF4 rabbit antibody
M00120-3 · IHCRat colon was stained with Anti-KLF4 rabbit antibody
M00120 · IHCImmunohistochemical analysis of paraffin-embedded mouse liver, using KLF4 Antibody.
M00120 · IFImmunofluorescent analysis of Hela cells, using KLF4 Antibody.
A00120-2 · IFFluorescent confocal image of SY5Y cells stained with A00120-2 KLF4 (C-term) antibody. SY5Y cells were fixed with 4% PFA (20 min), permeabil
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000136826-KLF4/tissue/cerebral+cortex#imid_1064512
HPA · EsophagusHuman Protein Atlas IHC, Esophagus. Source: https://www.proteinatlas.org/ENSG00000136826-KLF4/tissue/esophagus#imid_1064468
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000136826-KLF4/tissue/colon#imid_1064422
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000136826-KLF4/tissue/liver#imid_1064423
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA002926; green = KLF4, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA002926; green = KLF4, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for KLF4 IHC & IF
🧪Run bronchus first: respiratory epithelial cells should stain (HPA: High in bronchus respiratory epithelial cells). Use adipose tissue adipocytes as the negative tissue (HPA: Not detected in adipose tissue adipocytes); on the bronchus slide, cell-free areas should remain at background, while other cell types should serve as internal negatives only if independently verified as KLF4-negative.
Positive control tissue: Appendix (Endocrine cells, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show KLF4 in A-431, PC-3, U2OS, with annotated localisation: Nucleoplasm (approved) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control; an isotype control matched to the primary antibody’s host species and class (and subclass if monoclonal); and a KLF4 knockout sample as a biological negative. For chromogenic detection, quench endogenous peroxidase and check for endogenous biotin background because the selected tissue-IHC caption uses a streptavidin–biotin complex with DAB (A00120 tissue-IHC caption: SABC/DAB).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported in the supplied evidence, and the exact A00120 tissue-IHC caption does not state a fixative. The reported paraffin-section method uses heat retrieval in citrate buffer at pH 6 for 20 minutes; whether KLF4 staining depends on that retrieval condition has not been established by the supplied evidence (A00120 tissue-IHC caption). Frozen-section or IF processing cannot be judged easier from the supplied evidence; for bronchus, assess mucus-associated background separately from epithelial staining.
HPA tissue IHC evidence for KLF4
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | Endocrine cells | High | Protein (IHC) | HPA → |
| Bronchus | Respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Colon | Endocrine cells | High | Protein (IHC) | HPA → |
| Duodenum | Endocrine cells | High | Protein (IHC) | HPA → |
| Esophagus | Squamous epithelial cells | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | Glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | Cells in granular layer | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced KLF4 IHC Tips
Troubleshoot KLF4 staining in paraffin sections by checking retrieval, compartment, cell identity and controls before comparing chromogenic signal across samples.
How should I adjust retrieval when KLF4 nuclear staining is weak?
Start with heat-mediated citrate retrieval at pH 6 for 20 minutes (datasheet A00120). The catalog antibody produced staining in a paraffin-embedded rat small intestine section after this treatment, although the caption does not state the fixative (datasheet A00120). If nuclei remain weak, compare a modestly longer or shorter heating period on adjacent sections while holding antibody concentration, detection and DAB development constant (standard IHC practice). Judge the change by whether nuclear contrast improves without diffuse staining, using a positive tissue compartment and a no-primary control in the same run (HPA: nuclear expression in several tissues; standard IHC practice).
Could fixation explain weak or uneven KLF4 staining?
The selected tissue-IHC caption does not report a fixative, so target-specific KLF4 sensitivity to fixation is unknown (datasheet A00120). Record the specimen’s fixative, fixation interval and processing history before changing retrieval, and compare sections processed alike when assessing a staining difference (standard IHC practice). In a paired test, keep citrate retrieval at pH 6 for 20 minutes and the primary at 2 μg/ml overnight at 4 °C, matching the documented workflow (datasheet A00120). If a fixation change is unavoidable, assess nuclear contrast and morphology together; neither HPA tissue patterns nor KLF4 sequence features establish its effect on this antibody (standard IHC practice; UniProt O43474).
How should I assess cytoplasmic KLF4 staining in a paraffin section?
Score nuclei separately from cytoplasm because KLF4 is annotated in both compartments, while tissue IHC predominantly shows nuclear expression (UniProt O43474: nucleus and cytoplasm; HPA: nuclear tissue profile). Mark the cell boundary and nucleus with the counterstain before calling a cytoplasmic signal, particularly where adjacent cells overlap (standard IHC practice). Cytoplasmic staining alone needs stronger scrutiny if the expected epithelial or endocrine cell nuclei are unstained in the same section (HPA: high epithelial and endocrine staining; standard IHC practice). Compare its distribution with a no-primary control and exclude pigment or diffuse DAB before assigning biological meaning (standard IHC practice).
Can this antibody distinguish KLF4 isoforms or modified epitopes in IHC?
KLF4 has 5 annotated isoforms, but the supplied caption gives no epitope sequence or isoform selectivity for A00120 (UniProt O43474: isoforms 1–5; datasheet A00120). Its documented paraffin-section staining therefore cannot establish which isoform contributes to a positive nucleus (datasheet A00120; standard IHC interpretation). Phosphoserine at residue 254 and polyglutamylation at residue 411 are annotated, yet their effects on this antibody’s binding are unreported (UniProt O43474; datasheet A00120). If isoform or modification specificity matters, obtain epitope information and use independently validated controls before interpreting a change in IHC intensity as a molecular switch (standard IHC practice).
How can I check KLF4 localisation with multiplex IF?
Use IF as a complementary localisation check, with a marker identifying the expected epithelial or endocrine cell population beside KLF4 and a nuclear counterstain (HPA: high epithelial and endocrine staining; standard IF practice). Choose a far-red channel for the weaker signal where tissue autofluorescence crowds shorter wavelengths, and inspect single-channel controls before interpreting overlap (standard IF practice). Because KLF4 has no transmembrane segment and its main reported location is nucleoplasmic, assess nuclear access with controlled permeabilisation rather than treating it as a surface epitope (UniProt O43474: topology; HPA: nucleoplasm; standard IF practice). Compare IF compartments with the chromogenic IHC pattern, while keeping fixation and epitope accessibility differences in mind (standard IHC/IF practice).
What causes diffuse DAB or widespread nuclear background?
Separate antibody background from detection chemistry with no-primary and secondary-only sections, and check endogenous peroxidase blocking before DAB development (standard chromogenic IHC practice). The documented workflow used 10% goat serum, 2 μg/ml primary antibody overnight at 4 °C, and a biotin-based detection system (datasheet A00120). If diffuse staining persists, compare a lower primary concentration and shorter DAB development on adjacent sections while preserving the same retrieval conditions (standard IHC practice). Inspect tissue edges, folds and damaged regions separately; a broad brown deposit there does not establish KLF4 expression, even when nearby nuclei stain convincingly (standard IHC practice).
How should I quantify KLF4 staining across sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define the cell population and compartment before scoring, since KLF4 tissue staining is predominantly nuclear and varies among epithelial and endocrine cells (HPA: tissue profile). Report nuclear percentage positive and intensity, or calculate an H-score from intensity categories across the same defined population in every section (standard IHC practice). Normalise positive counts to the number of evaluable cells in that population; if reporting density per mm², normalise to the measured viable tissue area (standard IHC practice). Keep retrieval, imaging, threshold and DAB development consistent, and report cytoplasmic staining separately so it cannot inflate a nuclear score (standard IHC practice; UniProt O43474: cytoplasm).
How do I distinguish true KLF4 positivity from staining artefact?
Give greatest weight to discrete nuclear staining in the expected cell population, because HPA reports predominantly nuclear KLF4 in tissue and high staining in several epithelial and endocrine populations (HPA: tissue profile). Check cytoplasmic signal independently: cytoplasmic localisation is annotated, but diffuse colour across unrelated cells is insufficient evidence by itself (UniProt O43474: cytoplasm; standard IHC practice). Exclude section edges, folds, necrotic regions and endogenous enzyme signal by examining morphology and the no-primary control (standard IHC practice). Interpret a weak or absent compartment cautiously because HPA reports medium agreement between staining and RNA expression, and the selected caption does not specify fixation (HPA: Enhanced reliability description; datasheet A00120).
Boster reagents
Best KLF4 / Krueppel-like factor 4 IHC Antibodies
Validated anti-KLF4 antibodies have real IHC images from rat, mouse and human tissues, plus an IF image from SY5Y cells (catalog image captions); catalog reactivity covers human, mouse and rat (catalog reactivity).
Real IHC data
Anti-KLF4 Antibody ®
Cat # A00120
Real IHC data
Anti-KLF4 Antibody ®
Cat # A00120-3
Real IHC data
Anti-KLF4 Rabbit Monoclonal Antibody
Cat # M00120-3
Real IHC data
Anti-KLF4/Gklf Rabbit Monoclonal Antibody
Cat # M00120
Real IF data
Anti-KLF4 Antibody (C-term)
Cat # A00120-2
A00120 is pictured on rat small intestine, A00120-3 on mouse stomach, M00120-3 on mouse colon, and M00120 on mouse liver (each SKU’s IHC image caption). A00120-2 is pictured by IF in SY5Y cells (A00120-2 IF image caption).
Which to pick: For paraffin-section IHC, choose A00120-3: its mouse stomach image used EDTA retrieval at pH 8.0 and 2 μg/ml primary antibody; the fixative is unreported (A00120-3 IHC image caption). For IF/ICC, choose M00120 because both applications are listed and it has an IF image in Hela cells (M00120 applications and IF image caption). For tissue IHC across species, consider monoclonal M00120-3: its images show mouse, rat and human colon, but report no retrieval method or fixative (M00120-3 catalog description and IHC image captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry O43474 (KLF4_HUMAN, Krueppel-like factor 4).
- Human Protein Atlas. KLF4 tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. KLF4 subcellular location (ICC-IF): Mainly localized to the nucleoplasm. In addition localized to the cytosol and microtubules..
- Human Protein Atlas. KLF4 antibody validation summary (1 antibodies).
- High cytoplasmic expression of Krüppel-like factor 4 is an independent prognostic factor of better survival in hepatocellular carcinoma. International journal of molecular sciences 2014 — PMC4100128.
- Calmodulin-Like Protein 5 (CALML5) Expression in Squamous Cell Carcinoma of Esophagus and Oropharynx. Acta histochemica et cytochemica 2025 — PMC12173638.
- Role of Krüppel-like Factor 4-p21(CIP1) Axis in Breast Cancer Stem-like Cell Inhibition by Benzyl Isothiocyanate. Cancer prevention research (Philadelphia, Pa.) 2019 — PMC6401216.
- Elevated Krüppel-like factor 4 transcription factor in canine mammary carcinoma. BMC veterinary research 2011 — PMC3198687.
- PubMed PMID:9422764 — UniProt-cited evidence.
- PubMed PMID:10392904 — UniProt-cited evidence.
- PubMed PMID:23134681 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for KLF4 (Krueppel-like factor 4). Expected localisation Nuclear staining in several tissues (HPA tissue IHC). Antigen retrieval: Citrate pH 6 HIER, heat-mediated (datasheet A00120). Validated IHC antibody: A00120 at 2μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Appendix (Endocrine cells); negative Adipose tissue. IHC workflow; specimen preparation unspecified. Protocol steps: 1. Sample: Paraffin-embedded rat small intestine tissue; fixative not specified (datasheet A00120); 2. Fixation: Image fixative and duration unreported (datasheet A00120); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: Citrate pH 6 , 20 min (datasheet A00120); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A00120); 8. Primary antibody: Rabbit anti-KLF4, 2μg/ml (datasheet A00120); 9. Primary incubation: Overnight at 4 °C (datasheet A00120). Watch for: Fixation: Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A00120); Caveat: Staining varies by cell type across tissues (HPA tissue IHC); Isoform / epitope: Five isoforms; verify antibody epitope coverage (UniProt); Regulation: BTRC promotes KLF4 degradation (UniProt). Evidence: UniProt O43474, HPA tissue IHC · Enhanced, HPA ICC-IF · Mainly localized to the nucleoplasm. In addition localized to the…, Datasheet A00120, PMC4100128, PMC12173638. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/KLF4/immunohistochemistry-ihc-guide.